Women who test negative for human papillomavirus (HPV) at or after age 55 can likely forego cervical cancer screening for the rest of their lives, a new modeling study suggests. Although the risk for cervical cancer later in life could be decreased by screening women until age 75, the study model showed that women who test HPV DNA negative to 14 high-risk HPV types and stop screening at 55 have a remaining lifetime cervical cancer risk of less than 1 percent, reported Talia Malagon, PhD, of McGill University in Montreal, and colleagues in Lancet Oncology.  

Read more.